Cell Transplant
Cell Transplant market is segmented by region (country), players, by Type and by Application. Pla ... Read More
CAR T-Cell Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the CAR T-Cell Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Allogeneic
Autologous
Segment by Application
Hospitals
Cancer Research Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad
Cell Transplant market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Regenerative Cell market is segmented by region (country), players, by Type and by Application. P ... Read More
Gene Transplant market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Home Builder Software market is segmented by region (country), players, by Type and by Applicatio ... Read More